`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner,
`
`v.
`
`BRISTOL-MYERS SQUIBB COMPANY and PFIZER INC.,
`Patent Owners.
`
`
`U.S. Patent No. 9,326,945 to Patel et al.
`
`Inter Partes Review IPR2018-00892
`
`
`
`Before SHERIDAN K SNEDDEN, ZHENYU YANG, and
`KRISTI L. R. SAWERT, Administrative Patent Judges
`
`
`
`
`PETITIONER’S MOTION TO CORRECT A TYPOGRAPHICAL OR
`CLERICAL MISTAKE IN THE PETITION UNDER 37 C.F.R. § 42.104(c)
`
`
`
`
`
`
`
`
`
`I.
`
`
`
`INTRODUCTION AND RELIEF REQUESTED
`
`Pursuant to the Board’s November 20, 2018 Order (Paper No. 30), the Board
`
`authorized Petitioner to file a motion to correct inadvertent clerical/typographical
`
`errors in the Petition (Paper No. 2) and the Park Declaration (Ex. 1002) (“Park
`
`Decl.”) incorrectly referring to the Rudnic reference (Ex. 1010) as Chapter 10 of
`
`the fourth edition of the textbook Modern Pharmaceutics, rather than the third
`
`edition, and to file a separate motion (filed concurrently herewith) to submit
`
`supplemental information, that replaces Ex. 1010 with a clean copy of Rudnic (Ex.
`
`1042) thereby removing extraneous markings, the incorrect cover page and
`
`publishing information to the fourth edition and replacing it with the correct cover
`
`page and publishing information for the third edition. Therefore, pursuant to 37
`
`C.F.R. § 42.104(c), Petitioner requests that it be allowed to correct the
`
`typographical errors relating to Rudnic in both the Petition and the Park Decl. as
`
`proposed in APPENDIX A – PROPOSED CORRECTIONS attached hereto.
`
`II. DISCUSSION OF AUTHORITY AND MATERIAL FACTS
`
`The Board’s rules allow for correction of certain clerical and typographical
`
`mistakes. See Amkor Technology, Inc. v. Tessera, Inc., Case IPR2013-00242,
`
`2013 WL6907729, *2 (PTAB Aug. 29, 2013). Rule 42.104(c) provides:
`
`A motion may be filed that seeks to correct a clerical or typographical
`
`mistake in the petition. The grant of such a motion does not change the
`
`1
`
`
`
`
`
`filing date of the petition.
`
`37 C.F.R. § 42.104(c). Rule 42.104(c) is remedial in nature and has been liberally
`
`interpreted to allow not only the correction of clerical or typographical mistakes
`
`contained in a petition, but also for related documents filed in support of a petition.
`
`See, e.g., Amkor Technology, Inc., Case IPR2013-00242, 2013 WL6907729, at *3
`
`(granting motion to correct citation to wrong reference in petition); Emerson Elec.
`
`Co. v. Sipco, LLC, Case IPR2017–00260, 2017 WL 1952720, at *1 (PTAB May 9,
`
`2017) (granting motion to correct pinpoint citations in petition to corresponding
`
`exhibits); Abb Inc. v. Roy-G-Biv Corp., Case IPR2013-00063, 2013 WL 6907728,
`
`at *6 (PTAB Jan. 16, 2013) (granting motion to correct the uploading of incorrect
`
`exhibits in support of petition by replacing with correct exhibits)1; Syntroleum
`
`Corp. v. Nest Oil Oyj, Case IPR2013-00178, 2013 WL 5970108, at *3 (PTAB Jul.
`
`22, 2013) (same).
`
`Correction is especially appropriate here where no substantive changes are
`
`
`1 Petitioner understands that the Board has limited this motion to correcting the
`
`typographical errors in the Petition and the Park Decl. (see Order, Paper No. 30),
`
`but submits that 37 C.F.R. § 42.104(c) also provides for the correction of Rudnic
`
`(Ex. 1010) because the incorrect header portions (edition and publishing date) of
`
`Rudnic was due to a clerical error. Nevertheless, Petitioner limits this motion as
`
`ordered by the Board.
`
`2
`
`
`
`
`
`being proposed; therefore, the correction will not affect the notice function of the
`
`Petition in informing the Patent Owner or the Board of the grounds and
`
`supporting evidence for the petition. See Amkor Technology, Inc., Case IPR2013-
`
`00242, 2013 WL6907729, at *3-4 (finding no prejudice to patent owner by
`
`allowing petitioner to correct the disclosure of subject matter to a particular claim
`
`where the patent owner had notice of the substantive portions of a prior art
`
`reference relied on in the petition and had an opportunity to respond in its
`
`preliminary response).
`
`
`
`The Petition and the Park Decl. filed April 5, 2018 incorrectly refer to
`
`Rudnic (Ex. 1010) as Chapter 10 of the fourth edition of the textbook Modern
`
`Pharmaceutics published in 2002. (See generally, Second Supplemental Park
`
`Declaration (“Second Suppl. Park Decl.”) and Declaration of Karen L. Carroll
`
`(“Carroll Decl.”) submitted herewith). The citations should have instead referred
`
`to the third edition of Modern Pharmaceutics published in 1996 as the substantive
`
`portions of the Rudnic reference provided (i.e., Chapter 10) with the Petition were
`
`actually from the third edition of Modern Pharmaceutics rather than the fourth
`
`edition. (Id.) This clerical error occurred due to a third-party prior art search
`
`providing Petitioner with a copy of Chapter 10 of Modern Pharmaceutics from the
`
`third edition consisting of pages 333-359, without including a cover page,
`
`publication date information, or table of contents, but misidentifying that chapter
`
`3
`
`
`
`
`
`as coming from the fourth edition. (See Carroll Decl., ¶¶ 2-5; Second Suppl. Park
`
`Decl., ¶¶ 5-6). In reliance on the incorrect citation, Petitioner obtained the
`
`publication date information and cover from the fourth edition, combined those
`
`missing pages with Chapter 10 from the third edition, and filed that compilation as
`
`Ex. 1010.. (See Carroll Decl., ¶ 6; Second Suppl. Park Decl., ¶ 4). Accordingly,
`
`the substantive portions of Rudnic (i.e., Chapter 10), including all pinpoint page
`
`citations thereto, cited and discussed within the Petition and the Park Decl.
`
`correctly refer to Chapter 10 from the third edition submitted within Ex. 1010.
`
`(See Second Suppl. Park Decl., ¶ 5). Petitioner was unaware, however, of these
`
`errors until Patent Owners submitted a table of contents purporting to be from the
`
`fourth edition of Modern Pharmaceutics (Ex. 2019) with Patent Owners’
`
`Preliminary Response (Paper No. 18). (See Carroll Decl., ¶ 7). Thereafter,
`
`Petitioner investigated further by obtaining a complete copy of the fourth edition of
`
`Modern Pharmaceutics, comparing Chapter 10 from both editions, thereby
`
`discovering the error necessitating this motion. (See Carroll Decl., ¶ 8).
`
`
`
`Patent Owners will suffer no prejudice by the requested correction. First,
`
`the error did not prevent Patent Owners from addressing the substantive teachings
`
`of Rudnic in the Preliminary Response. (Prel. Resp., Paper No. 18, p. 16 and 23;
`
`Decision, Paper No. 24, p. 8). Second, Patent Owners have already admitted that
`
`“all prior art references relied on in Grounds 1–4 [including Rudnic] qualify as
`
`4
`
`
`
`
`
`
`
`prior art under the earliest possible priority date” and a POSA would understand
`
`that either edition of Rudnic predates the ’945 patent. (See Prel. Resp., Paper No.
`
`18, p. 9; Decision, Paper No. 24, p. 28; see also Second Suppl. Park Decl., ¶¶ 6-
`
`7). Thus, the error has not prejudiced Patent Owners, and neither would the
`
`proposed corrections, as there would be no change to the substantive teachings of
`
`Rudnic already addressed by Patent Owners. See Amkor Technology, Inc., Case
`
`IPR2013-00242, 2013 WL6907729, at*3-4 (granting motion to correct because
`
`“[t]he correction would not require [patent owner] to analyze or respond to any
`
`new citations or arguments in the Petition”); 37 C.F.R. § 42,1(b) (dictating that
`
`the Board’s rules “shall be construed to secure the just, speedy and inexpensive
`
`resolution of every proceeding”). Finally, Patent Owners can respond further in
`
`their Response due on January 15, 2019 (see Decision, Paper No. 24, p. 34;
`
`Sched. Order, Paper No. 25, p. 8). Accordingly, Petitioner respectfully requests
`
`that the Board grant the relief requested herein.
`
`Dated: November 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`Respectfully submitted,
`
`/ Robert L. Florence /
`Robert L. Florence (Reg. No. 54,933)
`Karen L. Carroll (Reg. No. 50,748)
`Sharad K. Bijanki (Reg. No. 73,400)
`Micheal L. Binns (Reg. No. 65,836)
`
`
`
`
`
`APPENDIX A – PROPOSED CORRECTIONS
`
`Corrections to Petition: Correct the following typographical errors contained
`
`within citations to Rudnic in the Petition (Paper No. 2) as proposed with redlining
`
`below:
`
`
`
`Change the sentence in footnote 7 on page 28 to recite “Rudnic, E.M.
`
`and M.K. Kottke, “Tablet Dosage Forms,” in Modern Pharmaceutics, 4th
`
`ed.3rd ed., G.S. Banker and C.T. Rhodes, eds., Taylor & Francis Group,
`
`Boca Raton, FL, pp. 333-359 (20021996) (“Rudnic” or Ex. 1010), published
`
`in 20021996, . . . .”
`
`
`
`Change the description of the Rudnic reference on page 5 of
`
`APPENDIX B: LISTING OF EXHIBITS to similarly recite “Rudnic et al.,
`
`“Tablet Dosage Forms,” in Modern Pharmaceutics, 4th ed.3rd ed., G.S.
`
`Banker and C.T. Rhodes, eds., Taylor & Francis Group, Boca Raton, FL, pp.
`
`333-359 (20021996).”
`
`
`
`Corrections to Park Decl.: Correct the following typographical errors
`
`contained within references to Rudnic in the Park Decl. (Ex. 1002) as proposed
`
`with redlining below:
`
`
`
`Change the description of the Rudnic reference in header ii on page 58
`
`to correctly recite “Ex. 1010 – Rudnic et al., “Tablet Dosage Forms,” in
`
`Modern Pharmaceutics, 4th ed.3rd ed., G.S. Banker and C.T. Rhodes, eds.,
`
`i
`
`
`
`
`
`Taylor & Francis Group, Boca Raton, FL, pp. 333-359 (20021996)
`
`(“Rudnic” or Ex. 1010).”; and, change the first sentence of paragraph 140 to
`
`recite “Rudnic was published in 20021996, and . . . .”
`
`ii
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioner’s Motion to Correct a Typographical or Clerical Mistake in the
`
`Petition Under 37 C.F.R. § 42.104(c) by email on this 26th day of November, 2018
`
`on the following attorneys of record:
`
`Heather M. Petruzzi
`Michael E. Nelson
`Amy K. Wigmore
`Wilmer Cutler Pickering Hale and Dorr LLP
`1875 Pennsylvania Ave, NW
`Washington, DC 20006
`E-mail: Heather.Petruzzi@wilmerhale.com
`E-mail: Michael.Nelson@wilmerhale.com
`E-mail: Amy.Wigmore@wilmerhale.com
`
`Timothy A. Cook
`Kevin M. Yurkerwich
`Kevin S. Prussia
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`E-mail: Tim.Cook@wilmerhale.com
`E-mail: Kevin.Yurkerwich@wilmerhale.com
`E-mail: Kevin.Prussia@wilmerhale.com
`
`Jason M. Okun
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`E-mail: JOkun@fchs.com
`
`Respectfully submitted,
`
`
`
`/ Robert L. Florence /
`Robert L. Florence, Lead Counsel
`Registration No. 54,933
`
`
`Dated: November 26, 2018
`
`
`
`